Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality

This publication has 15 references indexed in Scilit:

• Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
  New England Journal of Medicine, 1998
• Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2‐year follow‐up report of a national, prospective prostatic cancer study
  British Journal of Urology, 1998
• Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.
  Journal of Clinical Investigation, 1992
• Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population
  The Prostate, 1991
• Effect of Parenteral Oestrogen on the Coagulation System in Patients with Prostatic Carcinoma
  British Journal of Urology, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Cardiovascular follow‐up of patients with prostatic cancer treated with single‐drug polyestradiol phosphate
  The Prostate, 1987
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987
• Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.
  BMJ, 1986
• The Oestrogenic Effects of Ethinyl Oestradiol/Polyoestradiol Phosphate and Estramustine Phosphate in Patients with Prostatic Carcinoma A Comparative Study of Oestrogen Sensitive Liver Proteins, Gonadotrophins and Prolactin
  British Journal of Urology, 1986